We are live on ! Find out more
GCL

Glazer Capital LLC Portfolio holdings

AUM $4.71B
1-Year Est. Return 81.93%
This Fund
S&P 500
This Quarter Est. Return
+4.3%
1 Year Est. Return
+81.93%
3 Year Est. Return
+319.13%
5 Year Est. Return
+526.52%
10 Year Est. Return
+4,797.43%
AUM
$3.86B
AUM Growth
-$1.59B
Cap. Flow
-$1.68B
Cap. Flow %
-43.43%
Top 10 Hldgs %
19.14%
Holding
821
New
112
Increased
267
Reduced
93
Closed
295
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JWSM
1
DELISTED
Jaws Mustang Acquisition Corp.
JWSM
$131M 3.38%
12,928,498
+5,234,203
+68% +$52.5M
AAC
2
DELISTED
Ares Acquisition Corporation
AAC
$131M 3.38%
12,965,873
+2,980,873
+30% +$29.8M
HERA
3
DELISTED
FTAC Hera Acquisition Corp. Class A Ordinary Shares
HERA
$74.9M 1.94%
7,409,401
+1,049,285
+16% +$10.5M
STOR
4
DELISTED
STORE Capital Corporation
STOR
$70.1M 1.81%
2,186,382
+468,767
+27% +$14.9M
PNTM
5
DELISTED
Pontem Corporation
PNTM
$69.5M 1.8%
6,869,900
-15,100
-0.2% -$151K
SVFA
6
DELISTED
SVF Investment Corp. Class A Ordinary Shares
SVFA
$60M 1.55%
5,929,990
+2,089,181
+54% +$21M
LGAC
7
DELISTED
Lazard Growth Acquisition Corp. I Ordinary Shares
LGAC
$57.8M 1.5%
5,719,998
-5,002
-0.1% -$50.1K
SLAM
8
DELISTED
Slam Corp. Class A Ordinary Share
SLAM
$57.7M 1.49%
5,704,548
-30,452
-0.5% -$305K
VAQC
9
DELISTED
Vector Acquisition Corporation II Class A Ordinary Shares
VAQC
$45M 1.16%
4,455,718
-15,757
-0.4% -$158K
ACQR
10
DELISTED
Independence Holdings Corp. Class A Ordinary Share
ACQR
$43.6M 1.13%
4,324,461
+1,581,351
+58% +$15.8M
HZNP
11
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$41M 1.06%
+360,496
New +$29.9M
PDOT
12
DELISTED
Peridot Acquisition Corp. II
PDOT
$40.9M 1.06%
4,048,566
-20,334
-0.5% -$203K
FCAX
13
DELISTED
Fortress Capital Acquisition Corp.
FCAX
$39.6M 1.03%
3,921,719
+2,143,749
+121% +$21.5M
PRPC
14
DELISTED
CC Neuberger Principal Holdings III
PRPC
$38.6M 1%
3,818,552
+1,862,312
+95% +$18.7M
NAAC
15
DELISTED
North Atlantic Acquisition Corporation Class A Ordinary Share
NAAC
$37.9M 0.98%
3,751,241
+847,597
+29% +$8.5M
LHC
16
DELISTED
Leo Holdings Corp. II
LHC
$37.6M 0.97%
3,729,800
+391,358
+12% +$3.92M
SPWR icon
17
SunPower Inc
SPWR
$85.2M
$34.5M 0.89%
3,417,864
-15,136
-0.4% -$151K
TWNI
18
DELISTED
Tailwind International Acquisition Corp.
TWNI
$34.5M 0.89%
3,417,479
+84,065
+3% +$841K
TZPS
19
DELISTED
TZP Strategies Acquisition Corp. Class A Ordinary Share
TZPS
$34.5M 0.89%
3,410,340
+869,543
+34% +$8.7M
EVOP
20
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
$34M 0.88%
1,005,855
+414,385
+70% +$13.9M
ONYX
21
DELISTED
Onyx Acquisition Co. I Class A Ordinary Shares
ONYX
$33.9M 0.88%
3,281,113
+2,025,117
+161% +$20.7M
CLAA
22
DELISTED
Colonnade Acquisition Corp. II
CLAA
$32.6M 0.84%
3,236,275
+1,158,720
+56% +$11.6M
MVLA
23
DELISTED
Movella Holdings Inc. Common Stock
MVLA
$32.5M 0.84%
3,222,532
+207,274
+7% +$2.07M
LDTC
24
DELISTED
LeddarTech
LDTC
$32.4M 0.84%
6,421,556
+3,021,592
+89% +$15.2M
WPCB
25
DELISTED
Warburg Pincus Capital Corporation I-B
WPCB
$32.2M 0.83%
3,188,147
+391,325
+14% +$3.92M

Similar funds

Glazer Capital LLC's Q4 2022 Portfolio in Review

As of Q4 2022, Glazer Capital LLC held 821 positions worth $3.86B, down 29% from $5.46B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Glazer Capital LLC withdrew a net $1.68B in Q4 2022, closing 295 positions and reducing 93 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $187M position sold in full.

By sector, the portfolio is most concentrated in Financials at 69% of assets, up from 64% a quarter earlier, followed by Technology and Industrials.

Against the trend, Glazer Capital LLC opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $41M.

  • Glazer Capital LLC's largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 360,496 shares worth $41M.
  • Glazer Capital LLC added most to Jaws Mustang Acquisition Corp. in Q4 2022, an estimated $52.5M increase.
  • Glazer Capital LLC's biggest Q4 2022 reduction was Envoy Medical, cutting an estimated $34M.
  • Glazer Capital LLC fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $187M.
  • Glazer Capital LLC's ten largest holdings make up 19% of its $3.86B portfolio in Q4 2022.
  • Glazer Capital LLC opened 112 new positions and closed 295 in Q4 2022.
  • Glazer Capital LLC's portfolio value fell 29% quarter-over-quarter to $3.86B.

Based on Glazer Capital LLC's 13F filing for Q4 2022, filed 14 Feb 2023.